- Sunday, October 1, 2023
8:00 AM – 8:07 AM PT
100 - Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk DCIS after Breast Conserving Surgery: The Impact of a 7-Gene Biosignature BaseLocation: Room 6 B
Frank Vicini, MD, FASTRO – GenesisCare ### 1971959###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 8:10 AM – 8:17 AM PT
101 - Long Term Outcomes of Radiation (RT)-Monotherapy vs. Combined RT + Endocrine Therapy (RT+ET) in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older after Breast-Conserving Surgery (BCS)Location: Room 6 BPresenter: – Tumor Institute Radiation Oncology Group
Astrid Morris, MD, MS – Tumor Institute Radiation Oncology Group ### 1971960###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tumor Institute Radiation Oncology Group###Presenter: – Tumor Institute Radiation Oncology Group
### 8:20 AM – 8:27 AM PT
102 - Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving SurgeryLocation: Room 6 BPresenter: – Mayo Clinic Arizona
Brady Laughlin, MD – Mayo Clinic Arizona ### 1971961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 8:30 AM – 8:37 AM PT
103 - Impact of Neoadjuvant Concurrent Chemoradiation (NACCRT) on Operability and Survival in Locally Advanced Inoperable Breast CancerLocation: Room 6 BPresenter: – Cancer Institute (WIA)
Priya Iyer, MD, RT, MBBS – Cancer Institute (WIA) ### 1971962###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Institute (WIA)###Presenter: – Cancer Institute (WIA)
### 8:40 AM – 8:47 AM PT
104 - Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in IndiaLocation: Room 6 BPresenter: – Tata Memorial Centre
Rajiv Sarin, MD, FRCR – Tata Memorial Centre ### 2010637###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Centre###Presenter: – Tata Memorial Centre
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 6 BDiscussant: – Johns Hopkins University
Jean Wright, MD, FASTRO – Johns Hopkins University ### 524511###Discussant###Disclosures: Employment: Johns Hopkins University:Associate Professor, Radiation Oncology:Employee;National Institutes of Health:Associate Director, NINDS:Employee | Compensation: Up To Date: Other, Compensation Payment-End Date: present ;ASTRO: Other, Honoraria-End Date: present ;Oncospace: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Prostate Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Marshall Dennehy: Consultant, Compensation Payment-End Date: 9/22/22 ;Physicians Education Resource: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 3/3/2023 ;Elsevier Journals: Other, Honoraria-End Date: present | Ownership: none | Leadership: American Board of Radiology:Oral Board Examiner;ASTRO:Chair, Clinical Affairs and Quality Committee###Johns Hopkins University###Discussant: – Johns Hopkins University
### 8:00 AM – 8:07 AM PT
110 - STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung InjuryLocation: Room 32Presenter: – Zhongshan Hospital Fudan University
Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University ### 2130575###Presenter######Zhongshan Hospital Fudan University###Presenter: – Zhongshan Hospital Fudan University
### 8:10 AM – 8:17 AM PT
111 - Early and noninvasive PET imaging of radiation-induced lung injury by targeting CXCR4Location: Room 32Presenter: – Shandong Anti-Cancer Association
Jie Liu, MD – Shandong Anti-Cancer Association ### 1971968###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 8:20 AM – 8:27 AM PT
112 - Subacute Cutaneous Toxicity with Single-Fraction Electron FLASH RT in Yorkshire SwineLocation: Room 32Presenter: – The University of Texas M.D. Anderson Cancer Center
Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center ### 1971969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Texas M.D. Anderson Cancer Center###Presenter: – The University of Texas M.D. Anderson Cancer Center
### 8:30 AM – 8:37 AM PT
113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal InjuryLocation: Room 32Presenter: – The Second Affiliated Hospital of Soochow University
Haiyan Lu, MD – The Second Affiliated Hospital of Soochow University ### 1971970###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 8:30 AM – 8:37 AM PT
113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal InjuryLocation: Room 32Presenter: – The Second Affiliated Hospital of Soochow University
Ye Tian, MD – The Second Affiliated Hospital of Soochow University ### 2131439###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 8:40 AM – 8:47 AM PT
114 - HDAC-Mediated Glial Crosstalk Mediates Radiation Induced Memory Changes from Whole Brain Radiation in a Mouse ModelLocation: Room 32
Peter Mathen, MD – NIH/NCI ### 1971971###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NIH/NCI###Presenter: – NIH/NCI
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 32
Deborah Citrin, MD, FASTRO – NIH/NCI ### 746662###Discussant###Disclosures: Employment: National Cancer Institute:Senior Investigator:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###NIH/NCI###Discussant: – NIH/NCI
### 8:00 AM – 8:07 AM PT
105 - Clinical Validation of HPV ctDNA for Early Detection of Residual Disease Following Chemoradiation in Cervical CancerLocation: Room 5Presenter: – Princess Margaret Cancer Center, University Health Network
Kathy Han, MD, MS – Princess Margaret Cancer Center, University Health Network ### 535931###Presenter###Disclosures: Employment: Princess Margaret Cancer Center, University Health Network:Radiation Oncologist:Employee | Compensation: Advisory Board: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: Oct 2021 ;Grants: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: March 2027 ;Princess Margaret Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Aug 2023 | Ownership: HPV ctDNA patent pending:Copyright | Leadership: CCTG:Endometrial Cancer Working Group Co-Chair###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 8:10 AM – 8:17 AM PT
106 - Prognostic Impact of Mismatch Repair Deficiency on Stage I-II Endometrioid Endometrial Cancer Treated with Adjuvant Radiation Therapy: A Multi-Institutional AnalysisLocation: Room 5Presenter: – Rutgers Cancer Institute of New Jersey
Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey ### 1975183###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 8:20 AM – 8:27 AM PT
107 - HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive ChemoradiationLocation: Room 5Presenter: – MD Anderson Cancer Center
Aaron Seo, MD, PhD – MD Anderson Cancer Center ### 1972798###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 8:30 AM – 8:37 AM PT
108 - A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial CancerLocation: Room 5Presenter: – Northwestern Feinberg School of Medicine
Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine ### 1972241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Feinberg School of Medicine###Presenter: – Northwestern Feinberg School of Medicine
### 8:40 AM – 8:47 AM PT
109 - Mutational Landscape of ER Receptor Negative Endometrial Cancer Patients Categorized as No Specific Molecular Profile (NSMP)Location: Room 5Presenter: – Washington University St. Louis
Michael Waters, MD, PhD – Washington University St. Louis ### 535929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University St. Louis###Presenter: – Washington University St. Louis
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 5Discussant: – Rutgers Cancer Institute of New Jersey
Lara Hathout, MD, FRCPC – Rutgers Cancer Institute of New Jersey ### 535936###Discussant###Disclosures: Employment: Rutgers Cancer Institute of New Jersey:Associate Professor:Employee | Compensation: RTOG Foundation: Consultant, Compensation Payment-End Date: to present | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Discussant: – Rutgers Cancer Institute of New Jersey
### 8:05 AM – 8:10 AM PT
1000 - Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term ResultsLocation: Room 8Presenter: – Mount Vernon Hospital
Peter Hoskin, MD – Mount Vernon Hospital ### 524448###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Vernon Hospital###Presenter: – Mount Vernon Hospital
### 8:10 AM – 8:15 AM PT
1002 - Long-Term Outcomes of Prospective Clinical Trial HDR-Brachytherapy Monotherapy in Single Day in Patients with Localizated Prostate CancerLocation: Room 8Presenter: – Genesiscare UK (Oxford)
Elena Moreno-Olmedo, MD – Genesiscare UK (Oxford) ### 1972040###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesiscare UK (Oxford)###Presenter: – Genesiscare UK (Oxford)
### 8:15 AM – 8:20 AM PT
1004 - Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder CancerLocation: Room 8
Shang-Bin Qin, MD ### 747421###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 8:20 AM – 8:25 AM PT
1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled AnalysisLocation: Room 8Presenter: – Acibadem Adana Hospital
Gamze Ugurluer, MD – Acibadem Adana Hospital ### 535729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Acibadem Adana Hospital###Presenter: – Acibadem Adana Hospital
### 8:20 AM – 8:25 AM PT
1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled AnalysisLocation: Room 8Presenter: – Acibadem Maslak Hospital
Enis Ozyar, MD – Acibadem Maslak Hospital ### 747976###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Acibadem Maslak Hospital###Presenter: – Acibadem Maslak Hospital
### 8:25 AM – 8:30 AM PT
1008 - Prospective Comparative Study of Quality of Life in Bladder Cancer Patients Undergoing Cystectomy or Bladder PreservationLocation: Room 8Presenter: – Tata Memorial Centre
Vedang Murthy, MD – Tata Memorial Centre ### 525244###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Centre###Presenter: – Tata Memorial Centre
### 8:30 AM – 8:40 AM PT
1010 - Prognostication of Overall Survival in Muscle Invasive Bladder Cancer: An Application of a Lymph Node Metastasis NomogramLocation: Room 8
Garrett Harada, MD – UCI Health ### 1972652###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCI Health###Presenter: – UCI Health
### 9:30 AM – 9:40 AM PT
3 - Consolidative Radiotherapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab VedotiLocation: Ballroom 20Presenter: – Mayo Clinic Florida
Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida ### 535819###Presenter###Disclosures: Employment: Mayo Clinic:Professor of Radiation Oncology:Employee | Compensation: Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present | Ownership: none | Leadership: PTCOG:Secretary;NRG lymphoma working group:Co-Chair###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 9:40 AM – 9:50 AM PT
4 - Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer SurvivorsLocation: Ballroom 20Presenter: – Medical University of Vienna
Kathrin Kirchheiner, PhD, MSc – Medical University of Vienna ### 746728###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical University of Vienna###Presenter: – Medical University of Vienna
### 9:50 AM – 10:00 AM PT
5 - TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II)Location: Ballroom 20Presenter: – Peter MacCallum Cancer Centre
Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre ### 524764###Presenter###Disclosures: Employment: Peter MacCallum Cancer Centre:Radiation Oncologist:Employee | Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Remuneration Other-End Date: present ;Varian Medical Systems: Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: present ;Reflexion Medical Systems: Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: 2022 | Ownership: none | Leadership: ART committee of IASLC:committee member;Radiosurgery Society (RSS):Board Directoy###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 10:00 AM – 10:10 AM PT
6 - Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate CancerLocation: Ballroom 20Presenter: – Duke University Medical Center
W. Robert Lee, MD, MS, FASTRO, MEd – Duke University Medical Center ### 524570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 10:10 AM – 10:20 AM PT
7 - Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2Gy) vs. Standard Dose (70.2Gy) Radiation Therapy (RT) for Men with Localized Prostate CancerLocation: Ballroom 20Presenter: – Washington University St. Louis
Jeff Michalski, MD, MBA, FASTRO – Washington University St. Louis ### 1961865###Presenter###Disclosures: Employment: Washington University School of Medicine:Professor:Employee | Compensation: Michalski and Associates: Consultant, Travel Expenses, Compensation Payment-End Date: to present ;NCI: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present | Ownership: none | Leadership: NCI:Co-Chair;RTOG Foundation:Treasurer###Washington University St. Louis###Presenter: – Washington University St. Louis
### 10:20 AM – 10:30 AM PT
DiscussantLocation: Ballroom 20Discussant: – The Ohio State University
Dayssy Diaz Pardo, MD, MS – The Ohio State University ### 1974725###Discussant###Disclosures: Employment: The Ohio State University:Associate Professor:Employee | Compensation: ASCO: Education Meeting Faculty, Honoraria-End Date: 02/19/22 ;ASTRO: Education Meeting Faculty, Honoraria-End Date: 04/26/23 | Ownership: none | Leadership: The Ohio State University:Vice-Chair of DEI###The Ohio State University###Discussant: – The Ohio State University
### 10:20 AM – 10:30 AM PT
LBA 05 - Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy After Implant-Based RecLocation: Ballroom 20Presenter: – Dana-Farber Cancer Institute
Rinaa Punglia, MD, FASTRO, MPH – Dana-Farber Cancer Institute ### 524819###Presenter###Disclosures: Employment: DFCI/BWH:Attending physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
### 10:30 AM – 10:40 AM PT
LBA 06 - Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup AnalysisLocation: Ballroom 20Presenter: – Calvary Mater Newcastle Hospital
Swetha Sridharan, MBBS – Calvary Mater Newcastle Hospital ### 2105487###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Calvary Mater Newcastle Hospital###Presenter: – Calvary Mater Newcastle Hospital
### 10:40 AM – 10:50 AM PT
LBA 07 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) TrialLocation: Ballroom 20Presenter: – Technical University of Munich (TUM), Radiation Oncology
Denise Bernhardt, MD – Technical University of Munich (TUM), Radiation Oncology ### 1972263###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University of Munich (TUM), Radiation Oncology###Presenter: – Technical University of Munich (TUM), Radiation Oncology
### 4:50 PM – 4:55 PM PT
1012 - Development and Evaluation of a Mobile App for Radiotherapy Patient EducationLocation: Room 8Presenter: – Hospital Universitario
Jose Felipe Munoz Lozano, MD – Hospital Universitario ### 1972042###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Universitario###Presenter: – Hospital Universitario
### 4:55 PM – 5:00 PM PT
1014 - Association of Parental Status and Gender with Burden of Multidisciplinary Tumor BoardsLocation: Room 8
Brittney Chau, MD – USC ### 1972043###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###USC###Presenter: – USC
### 5:00 PM – 5:05 PM PT
1016 - Teaching Trainees to be Effective Mentors: A Needs-Based Assessment in Radiation OncologyLocation: Room 8Presenter: – Brigham and Women's Hospital/Dana-Farber
Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber ### 537850###Presenter###Disclosures: Employment: Brigham Womens Hospital:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:05 PM – 5:10 PM PT
1018 - Quality of Life In Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-LinacLocation: Room 8Presenter: – Medical College of Wisconsin
Sara Beltran Ponce, MD – Medical College of Wisconsin ### 538557###Presenter###Disclosures: Employment: Medical College of Wisconsin Affiliated Hospitals:Resident Physician:Employee | Compensation: American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 11/2023 | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:10 PM – 5:15 PM PT
1020 - A Randomized Standard-of-Care Controlled Trial of Xenogeneic Platelet-Rich Plasma Lotion to Reduce Acute Radiation Dermatitis in Breast Cancer PatientsLocation: Room 8Presenter: – Tri-Service General Hospital
Chun-Shu Lin, MD, PhD – Tri-Service General Hospital ### 537922###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tri-Service General Hospital###Presenter: – Tri-Service General Hospital
### 5:15 PM – 5:20 PM PT
1022 - Harnessing Electronic Patient-Reported Outcomes (ePRO) in Routine Care to Promote Clinical Trial Enrollment: A Randomized StudyLocation: Room 8Presenter: – Tufts University School of Medicine
Nicholas Verdini, BS – Tufts University School of Medicine ### 1972044###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tufts University School of Medicine###Presenter: – Tufts University School of Medicine
### 4:45 PM – 4:52 PM PT
115 - Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-Gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm TrialLocation: Room 1Presenter: – Duke Cancer Institute
Pooja Karukonda, MD – Duke Cancer Institute ### 525023###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke Cancer Institute###Presenter: – Duke Cancer Institute
### 4:55 PM – 5:02 PM PT
116 - Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal CancerLocation: Room 1Presenter: – City of Hope
Yufei Liu, MD, PhD – City of Hope ### 1971972###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope###Presenter: – City of Hope
### 5:05 PM – 5:12 PM PT
117 - Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical TrialLocation: Room 1Presenter: – Zhejiang Cancer Hospital
Yang Yang, MD, DO, PhD – Zhejiang Cancer Hospital ### 1971973###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhejiang Cancer Hospital###Presenter: – Zhejiang Cancer Hospital
### 5:15 PM – 5:22 PM PT
118 - Electrocardiogram with Artificial Intelligence Assessment as a Predictor of Cardiac Events and Overall Survival in Patients Receiving Radiotherapy for Esophageal CancerLocation: Room 1Presenter: – Mayo Clinic College of Medicine and Science Rochester
Roman Kowalchuk, MD, BS – Mayo Clinic College of Medicine and Science Rochester ### 1971974###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 5:25 PM – 5:32 PM PT
119 - Utilization of the Triangle Volume in Patients with Localized PDAC Undergoing Pre-Operative SBRT: Report of Early OutcomesLocation: Room 1Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 1971975###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:35 PM – 5:42 PM PT
120 - Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancerLocation: Room 1Presenter: – Miami Cancer Institute
Michael Chuong, MD – Miami Cancer Institute ### 525437###Presenter###Disclosures: Employment: Baptist Health South Florida:physician:Employee | Compensation: ViewRay: Consultant, Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria, Travel Expenses, In-kind Donations, Compensation Payment-End Date: to present ;Novocure: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;StratPharma: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Sirtex: Speaker's Bureau, Honoraria-End Date: to present | Ownership: none | Leadership: Proton Collaborative Group:Board of Directors member###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 1Discussant: – Cedars-Sinai Medical Center
Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center ### 535835###Discussant###Disclosures: Employment: Cedars-Sinai Medical Center:Assistant Professor:Employee | Compensation: OncLive: Education Meeting Faculty, Honoraria-End Date: 04/2021 | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Discussant: – Cedars-Sinai Medical Center
### 4:45 PM – 4:52 PM PT
127 - Deep Learning-Based Natural Language Processing to Automate Esophagitis Severity Grading from the Electronic Health RecordsLocation: Room 32Presenter: – Harvard Medical School
Shan Chen, MS – Harvard Medical School ### 1975156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Medical School###Presenter: – Harvard Medical School
### 4:55 PM – 5:02 PM PT
128 - Operational Ontology for Radiation Oncology (OORO): A Professional Society-Based, Multi-Stakeholder Consensus Driven Informatics Standard Supporting Clinical and Research Use of Real-World DataLocation: Room 32
Amanda Caissie ### 2149159###Presenter#########Presenter:
### 5:05 PM – 5:12 PM PT
129 - A Prospective Study of Machine Learning-Assisted Radiotherapy Planning for Patients Receiving 54 Gy to the BrainLocation: Room 32Presenter: – Princess Margaret Cancer Centre
Derek Tsang, MD, MS – Princess Margaret Cancer Centre ### 525202###Presenter###Disclosures: Employment: University Health Network:Radiation Oncologist:Employee | Compensation: Elekta: Education Meeting Faculty, Travel Expenses-End Date: 12/2022 | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 5:15 PM – 5:22 PM PT
130 - Curietherapy User eXperience Pilot Study: A Novel Augmented Reality Educational Tool during Radiation Oncology Consultation for Patients with Breast CancerLocation: Room 32Presenter: – NYU Grossman School of Medicine
David Byun, MD – NYU Grossman School of Medicine ### 747830###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 5:25 PM – 5:32 PM PT
131 - Improving Dose Volume Histogram (DVH) Based Analysis of Clinical Outcomes Using Modern Statistical Techniques: A Systematic Answer to Multiple Comparisons ConcernsLocation: Room 32Presenter: – Mayo Clinic Arizona
Mirek Fatyga, PhD – Mayo Clinic Arizona ### 536051###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 5:35 PM – 5:42 PM PT
132 - Clinical Acceptability of Artificial Intelligence-Screened Interstitial Lung Disease (AI-ILD) in Lung Cancer Patients Treated with RadiotherapyLocation: Room 32Presenter: – University of Toronto
Nicholas McNeil, MBBS – University of Toronto ### 1975157###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 32Discussant: – Brigham and Women's Hospital
Danielle Bitterman, MD – Brigham and Women's Hospital ### 538515###Discussant###Disclosures: Employment: Brigham and Women's Hospital:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: HemOnc.org:Associate Editor, Radiation Oncology###Brigham and Women's Hospital###Discussant: – Brigham and Women's Hospital
### 4:45 PM – 4:52 PM PT
121 - Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented PopulationsLocation: Room 4Presenter: – Stanford Health Care
Kekoa Taparra, MD, PhD – Stanford Health Care ### 535869###Presenter###Disclosures: Employment: Stanford Health Care:Resident Physician:Employee | Compensation: Lancet: Other, Honoraria-End Date: 6/2022 ;Stanford CARE: Other, Honoraria-End Date: 3/2023 ;MDACC: Other, Honoraria-End Date: 5/2023 | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 4:55 PM – 5:02 PM PT
122 - The Impact of a Precision Medicine Navigator on Inequities Associated with Utilization of Genomic Tests in Black Men with Prostate CancerLocation: Room 4Presenter: – University of Maryland Medical Center
Alexander Allen, MD – University of Maryland Medical Center ### 1972178###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Medical Center###Presenter: – University of Maryland Medical Center
### 5:05 PM – 5:12 PM PT
123 - Improving Sexual Orientation and Gender Identity Documentation at an NCI-Designated Comprehensive Cancer CenterLocation: Room 4Presenter: – NYU Langone Laura and Isaac Perlmutter Cancer Center
Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center ### 525196###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Laura and Isaac Perlmutter Cancer Center###Presenter: – NYU Langone Laura and Isaac Perlmutter Cancer Center
### 5:15 PM – 5:22 PM PT
124 - State Mandatory Paid Family Leave and Survival among Children with CancerLocation: Room 4Presenter: – Washington University School of Medicine
Justin Barnes, MD, MS – Washington University School of Medicine ### 595915###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 5:25 PM – 5:32 PM PT
125 - Under-Representation for Female Cancers in Commercial Auto-Segmentation Solutions and Open-Source Imaging DatasetsLocation: Room 4Presenter: – Memorial Sloan Kettering Cancer Center
Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center ### 535996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:35 PM – 5:42 PM PT
126 - Impact of Free Hospital-Provided Rideshare Service on Radiation Therapy Completion Rates: A Matched Cohort AnalysisLocation: Room 4Presenter: – University Hospitals Seidman Cancer Center
Eric Chen, MD – University Hospitals Seidman Cancer Center ### 1975179###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospitals Seidman Cancer Center###Presenter: – University Hospitals Seidman Cancer Center
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 4Discussant: – Dana-Farber/Brigham and Women's Cancer Center
Idalid Franco, MD, MPH – Dana-Farber/Brigham and Women's Cancer Center ### 854606###Discussant###Disclosures: Employment: Brigham and Women's Hospital Dana-Farber CC:Radiation Oncologist:Employee | Compensation: Diversity Supplement, National Cancer Institute: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;NIH/NCI Loan Repayment Program: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Brigham and Women's Hospital Dana-Farber CC: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: Present | Ownership: none | Leadership: Association of Residents in Radiation Oncology:Executive Vice Chair;American Society of Radiation Oncology ASTRO:Vice Chair###Dana-Farber/Brigham and Women's Cancer Center###Discussant: – Dana-Farber/Brigham and Women's Cancer Center
###